β受体阻断药Nebivolol的合成工艺

doi:10.16085/j.issn.1000-6613.2016.s2.051

化工进展 ›› 2016, Vol. 35 ›› Issue (S2): 295-300.DOI: 10.16085/j.issn.1000-6613.2016.s2.051

β受体阻断药Nebivolol的合成工艺

吴成军, 马阳, 李娜, 吕海宁, 孙铁民

沈阳药科大学创新药物研究与设计教育部重点实验室, 辽宁沈阳 110016

收稿日期:2016-09-26 出版日期:2016-12-31 发布日期:2016-12-22
通讯作者: 孙铁民,教授,博士研究生导师,主要从事天然产物合成和半合成、手性药物合成以及抗病毒药物的合成研究。E-mail:suntiemin@126.com。
作者简介:吴成军,男,博士研究生,主要从事药物合成研究。

Study on the synthesis of Nebivolol, a-aderenergic blocker

WU Chengjun, MA Yang, LI Na, LÜ Haining, SUN Tiemin

Shenyang Pharmaceutical University Innovation Laboratory of Drug Research and Design, Ministry of Education, Shenyang 110016, Liaoning, China

Received:2016-09-26 Online:2016-12-31 Published:2016-12-22

摘要/Abstract

摘要： 为了手性合成新型β受体阻断药Nebivolo，通过对文献路线的分析，基于经济高效的原则，选择了一条合理的合成路线，分别以廉价的维生素C和D-甘露醇作为手性源，通过环合反应的过程生成另一对手性碳。这样得到的非对映异构体，经过结晶得到光学纯的手性中间体，因而解决了结构中的构型问题。总共经过10步反应，成功地对Nebivolol进行了化学合成。改进后的新合成路线总收率12.7%，优化了合成路线，提高了收率，降低了成本，且节能环保。

关键词: β受体阻断药, Nebivolol, 手性中间体, 化学合成

Abstract: Aim to synthesize Nebivolol, as a new type of β-anderenergic blocker.We choose a rational synthesis route to prepare it.We choose two cheap compounds-Vitamin C and D-Mannitol as one source of chiral carbon.By the ring-closure reaction in the synthesis route, we introduce another two chiral points and get a mixture of two pseudosymmetric isomers.So we can get optical-pure intermediates by crystallization of the mixture and successfully resolve the problem of configuration.Finally, we complete the synthesis of Nebivolol by 10-step reaction.The overall yield is 12.7%.The synthetic method is also intensively studied and optimized in order to low-down the cost, simplify the operating procedure, and the yield gets better as well.

Key words: β-anderenergic blocker, Nebivolol, chiral intermediates, synthesis

中图分类号:

TQ463

吴成军, 马阳, 李娜, 吕海宁, 孙铁民. β受体阻断药Nebivolol的合成工艺[J]. 化工进展, 2016, 35(S2): 295-300.

WU Chengjun, MA Yang, LI Na, LÜ Haining, SUN Tiemin. Study on the synthesis of Nebivolol, a-aderenergic blocker[J]. Chemical Industry and Engineering Progree, 2016, 35(S2): 295-300.

参考文献

[1] LIAPPAS G, GONZALEZ-MATEO G, AGUIRRE A R, et al.Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis[J].Oncotarget, 2016.
[2] MARTIJN AW, PIETEER A, BAS C, et al.Nebivolol:a third generation β₂blocker that augments vascular nitric oxide release endothelial β₂Adrenergic receptor mediated nitric oxide production[J].Circulation, 2000,102:677-684.
[3] VELASCO A, SOLOW E B, PRICE A L, et al.Differential effects of nebivolol vs metoprolol on microvascular function in hypertensive humans[J].American Journal of Physiology.Heart and Circulatory Physiology, 2016:ajpheart.00237.2016-ajpheart.00237.2016.
[4] MASON R P, JACOB R F, MALINSKI T.Nebivolol and valsartan increase nitric oxide release from human endothelial cells in a synergistic fashion[J].Hypertension, 2014, 64(Suppl 1):A648-A648.
[5] MCNEELY W, GOAKL.Nebivolol in the management of essential hypertension[J].Drugs, 1999,57(4):633-651.
[6] FREIFELD I, JAS G, KESSELER K, et al.Most effective process for base-free preparation of ketone intermediates usable for manufacture of nebivolol:U S Application 14/621414[P].2015-02-13.
[7] XHONNEUSX R M, VAN LOMMEN G R E.Agents for lowering blood pressure:EP 334429[P].
[8] JOHANNES C W, VISSER M S, WEATHERHEAD G S, et al.Zr-catalyzed kinetic resolution of allylic ethers and Mo-catalyzed chromene formation in synthesis.Enantioselective total synthesis of the antihypertensive agent (S, R, R, R)-Nebivolol[J].Journal of the American Chemical Society, 1998, 120(33):8340-8347.
[9] BARTOLI S, CIPOLLONE A, FATTORI D.Process for the preparation of nebivolol:US 8487122[P].2013-07-16.
[10] VOLPICELLI R, MARAGNI P, COTARCA L, et al. Process for preparing nebivolol:US 7960572[P].2011-06-14.
[11] SCHMID C R, Bryant J D.D-(R)-glyceraldehyde acetonide[J].Organic Syntheses, 6-6.
[12] KUSZMANN J, TOMORI É, MEERWALD I.The synthesis of 1, 2,5,6-di-O-isopropylidene-d-mannitol:a comparative study[J].Carbohydrate Research, 1984, 128(1):87-99.
[13] HUBSCHWERLEN C.A convenient synthesis of L-(S)-glyceraldehyde acetonide from L-ascorbic acid[J]. Synthesis, 1986(11):962-964.
[14] SANYAL I, SHUKLA B, BARMAN P D, et al.Stereoselective synthesis of (S)-oxiracetam and (S)-GABOB from (R)-glyceraldehyde acetonide[J]. Tetrahedron Letters, 2013, 54(21):2637-2640.
[15] LISKO K A, TORRES R, HARRIS R S, et al.Elevating vitamin C content via overexpression of myo-inositol oxygenase and L-gulono-1,4-lactone oxidase in Arabidopsis leads to enhanced biomass and tolerance to abiotic stresses[J]. In Vitro Cellular & Developmental Biology-Plant, 2013, 49(6):643-655.

β受体阻断药Nebivolol的合成工艺

Study on the synthesis of Nebivolol, a-aderenergic blocker

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

本文评价

[1]	孙晖, 孟祥海, 魏景海, 周红军, 徐春明. 绿电制氢生产氨的新场景与实践[J]. 化工进展, 2023, 42(2): 1098-1102.
[2]	毛信表, 蔡萍萍, 张寅旭, 何峰强, 马淳安. 离子液体中电活化CO₂合成有机碳酸酯的研究进展[J]. 化工进展, 2015, 34(3): 825-830,856.
[3]	孙旭辉，郑文平，庹万权，于海辉，王冬. 电化学合成法制备高铁酸盐的研究进展[J]. 化工进展, 2014, 33(06): 1380-1386.
[4]	王维大1，2，李浩然2，冯雅丽1，唐新华3，杜竹玮2，杜云龙1. 微生物燃料电池的研究应用进展[J]. 化工进展, 2014, 33(05): 1067-1076.
[5]	马强强，赵广荣. 左旋多巴合成研究进展[J]. 化工进展, 2013, 32(06): 1367-1371.
[6]	谌容1，2 ，王秋岩1，殷晓浦1，魏东芝2，谢恬1. 醇脱氢酶不对称还原制备手性醇的研究进展 [J]. 化工进展, 2011, 30(7): 1562-.
[7]	马烽，杨晓勇，陈明辉. 微波膨化钾-四氢呋喃-石墨层间化合物制备膨胀石墨 [J]. 化工进展, 2010, 29(9): 1715-.
[8]	齐济1，宁桂玲2，刘俊龙3，王琛1. 二氧化钒粉体研究的新进展 [J]. 化工进展, 2010, 29(8): 1513-.
[9]	董广新，蒋稼欢. 基于微流动混合的微纳米粒子合成进展 [J]. 化工进展, 2010, 29(11): 2026-.
[10]	曾炜，陈丰秋，詹晓力. 乳酸的生产技术及其研究进展 [J]. 化工进展, 2006, 25(7): 744-.
[11]	念保义，徐刚，杨立荣. l–薄荷醇的合成及手性拆分研究进展 [J]. 化工进展, 2006, 25(4): 401-.